Skip Ribbon Commands
Skip to main content
Investors
Webcasts and Presentations
NYSE: WSTSee Quotes >>
LAST: 56.86 4:03 p.m. ET
Change: -0.23    -.40%
See Chart >>

Shareholders may receive, free of charge, a hard copy of West Pharmaceutical Service's complete audited financial statements by sending a written request to West Pharmaceutical Services, Inc. Attn: Company's Secretary, 530 Herman O. West Drive, Exton, PA 19341.

Latest Releases
7/30/2015 7:01:02 AM
West Announces Second Quarter 2015 Results
7/23/2015 4:15:50 PM
West to Host Second Quarter 2015 Conference Call
7/20/2015 8:00:38 AM
West Expands Manufacturing Capacity at Scottsdale Facility to Support Customer Demand for SmartDose® Electronic Wearable Injector
Corporate Overview

West Pharmaceutical Services, Inc. is a global pharmaceutical technology company that applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines and consumer healthcare products.

West is the world's premiere provider of standard-setting systems and device components for parenterally administered medicines.

Internationally headquartered in Exton, Pa., West supports its partners and customers from 50 locations throughout North America, South America, Europe, and the Asia Pacific region.

Investor Contacts

Michael A. Anderson
Vice President and Treasurer
610-594-3345
Mike.Anderson@westpharma.com


John Woolford
Westwicke Partners
443-213-0506
John.woolford@westwicke.com